Research programme: PPAR alpha agonists - CrystalGenomicsAlternative Names: PPAR alpha agonists - CrystalGenomics
Latest Information Update: 07 Feb 2011
At a glance
- Originator CrystalGenomics
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity